Orforglipron Price: What Foundayo Costs With and Without Insurance

Foundayo, the brand name of orforglipron, costs $149 to $349 a month if you pay cash through Lilly, depending on the tablet strength, and as little as $25 a month with commercial insurance that covers it. The list price is $649 a month for every strength. Every price below was read on Lilly's and the government's own pages on 8 November 2026; several end on 31 December 2026, so check the date before you rely on one. For the drug itself, see orforglipron (Foundayo).

Foundayo cost without insurance: LillyDirect self-pay

LillyDirect sells a 30-tablet month for cash with a prescription (LillyDirect, terms). The price rises with the dose:

Lilly's footnote: "Self-pay only. Prescription required. Additional taxes and fees may apply. Month is defined as 30-days. NOT INSURANCE." The pharmacies behind LillyDirect are Amazon Pharmacy, Fuze Health, Gifthealth and Walmart Pharmacy, with free shipping or retail pick-up. Lilly says Foundayo is also sold through telehealth providers and US retail pharmacies (Lilly medical information).

What the first six months cost

The label steps the dose up no faster than every 30 days: 0.8, 2.5, 5.5, 9, 14.5 and 17.2 mg. Paying cash for one month at each step costs $1,394 at the prices on 8 November 2026, or $1,644 at the regular prices. Our arithmetic, not a Lilly figure, and many people stop at a lower dose, which costs less.

With insurance: the $25 savings card

Lilly's card says: "If you are eligible and commercially insured with coverage for Foundayo, you could pay as low as $25 a month." The terms cap the saving at $100 for a one-month fill and $1,000 a year, so $25 only holds when your plan's charge is within $100 of it. The card is for people on commercial plans, not Medicare, Medicaid, TRICARE or the VA, and it expires on 31 December 2026 (Lilly terms). If your commercial plan does not cover Foundayo, the same card gives you the self-pay prices above.

List price and TrumpRx

• List price (WAC): $649 for a 30-tablet pack of any strength, Lilly's April 2026 disclosure (Lilly WAC sheet). That is what wholesalers are charged before discounts, not what most patients pay. Whether it has changed since April we have not verified.
• TrumpRx lists Foundayo "Starting at $149.00" and sends buyers to LillyDirect; it states the same reduced 2.5 mg and 5.5 mg prices (TrumpRx).
• The deal behind it. The White House said in November 2025 that "The price of Zepbound and Orforglipron, if approved, will fall from $1,086 per month to an average of $346 when purchased through TrumpRx" (White House fact sheet).

Medicare and Medicaid

From 1 July 2026 to 31 December 2027 Medicare runs a demonstration, the Medicare GLP-1 Bridge, in which "Eligible beneficiaries will have a $50 copay" (CMS). All Foundayo strengths are on it, alongside Wegovy and the Zepbound KwikPen; coupons cannot be stacked on it (CMS pharmacy FAQ). Lilly lists the criteria: 18 or older, on Part D, using it for weight and not for diabetes, sleep apnoea or fatty liver, and a BMI of 35 or more, or 27 or more with certain weight-related conditions, with prior authorisation from the prescriber (Lilly Medicare page). For Medicaid, the White House said state programmes "will also have access to these medications at these prices"; whether your state covers Foundayo, we have not verified.

Foundayo cost vs Zepbound and the Wegovy pill

The Zepbound month is 28 days (four vials or one KwikPen), the tablet months are 30. The Wegovy pill price is from TrumpRx. Effect sizes differ too: see Foundayo vs Zepbound.

Outside the US

The UK's MHRA authorised Foundayo on 10 August 2026 but said it "is not available currently via the NHS" (MHRA); the EMA recommended EU authorisation on 16 October 2026, with price and reimbursement left to each member state (EMA). We found no published price outside the US.

Cheap "research" orforglipron

Orforglipron is approved only as Foundayo from Eli Lilly. A powder or capsule sold online as research orforglipron is not that product and has had no FDA review; the FDA warns about GLP-1 products "falsely labeled 'for research purposes' or 'not for human consumption'" (FDA). We do not list any.

Frequently asked questions

How much does Foundayo cost without insurance?

Through LillyDirect, $149 a month for 0.8 mg and, until 31 December 2026, $149 for 2.5 mg and $199 for 5.5 mg; $299 for 9 mg; and $299 for 14.5 mg and 17.2 mg if refilled within 45 days, otherwise $349. Prices as read on 8 November 2026.

What is the list price of orforglipron?

Lilly's wholesale acquisition cost for Foundayo is $649 for a 30-tablet pack of any strength, per its April 2026 disclosure. Most patients pay a self-pay or insured price well below that.

Does insurance cover Foundayo?

It depends on the plan. With commercial coverage for Foundayo, Lilly's savings card brings the cost to as little as $25 a month, capped at $100 of savings a month and $1,000 a year, until 31 December 2026.

Does Medicare cover Foundayo?

Through the Medicare GLP-1 Bridge, from 1 July 2026 to 31 December 2027, eligible Part D members pay a $50 copay for Foundayo, with prior authorisation and BMI criteria. It is for weight management, not diabetes.

Is Foundayo cheaper than Zepbound?

At self-pay prices, yes: Foundayo runs $149 to $349 a month against $299 to $699 for Zepbound vials or KwikPen. Zepbound produced more weight loss in its trials, so cost per kilogram lost is a different question.

How much do the first six months of Foundayo cost?

One month at each of the six label steps, 0.8 mg to 17.2 mg, costs $1,394 at LillyDirect prices on 8 November 2026, or $1,644 at regular prices. That is our arithmetic, not a Lilly figure.

Sources (checked 8 November 2026)

1. LillyDirect, Foundayo self-pay pricing (CMAT-19155 09/2026). Checked 8 November 2026.
2. LillyDirect, Foundayo full terms and conditions, self-pay and savings card. Checked 8 November 2026.
3. Lilly, Colorado WAC disclosure sheet, Foundayo, April 2026. Checked 8 November 2026.
4. TrumpRx, Foundayo listing. Checked 8 November 2026.
5. White House fact sheet on most-favored-nation pricing, 6 November 2025. Checked 8 November 2026.
6. CMS, Medicare GLP-1 Bridge. Checked 8 November 2026.
7. CMS, Medicare GLP-1 Bridge information for pharmacies. Checked 8 November 2026.
8. Lilly, Medicare GLP-1 Bridge eligibility. Checked 8 November 2026.
9. Lilly medical information: is Foundayo approved and is it available. Checked 8 November 2026.
10. LillyDirect, Zepbound self-pay pricing (CMAT-05333 10/2026). Checked 8 November 2026.
11. TrumpRx, Wegovy pill listing. Checked 8 November 2026.
12. UK first in Europe to authorise orforglipron, MHRA, 10 August 2026. Checked 8 November 2026.
13. New oral GLP-1 medicine for weight management and type 2 diabetes, EMA, 16 October 2026. Checked 8 November 2026.
14. FDA's concerns with unapproved GLP-1 drugs used for weight loss. Checked 8 November 2026.

Prices are as read on 8 November 2026 on the pages listed and change often; they are not a quote. Labels and trial records change; the leaflet in your box and your prescriber come first. Educational content, not medical advice.